Dr. Jan Petracek in the Programme Committee at DIA Workshop Benefit/Risk Strategy June 15-16 2017, Prague

Jan Petracek PrimeVigilance and PharmInvent’s CEO will be sharing his expertise as part of the Programme Committee for DIA’s upcoming Workshop on Benefit/Risk Strategy taking place on June 15th – 16th at the Hotel Grand Majestic Plaza in Prague, Czech Republic.

This workshop is designed to specifically discuss benefit/risk assessment, challenges and solutions related to it within different departments or an organization. Additionally, there will be discussion regarding the impact of the new guidelines and interpretations of them. The workshop brings together regulators and industry from both regulatory and pharmacovigilance departments to discuss the strategic developments within the framework of benefit/risk assessment.

If you wish to meet Jan Petracek to discuss any pharmacovigilance and medical information needs please contact us to schedule a meeting.

For more information on the event please visit the DIA website.

 

 

Share this:

 


NEXT NEWS:

PREVIOUS NEWS:

This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Cookie Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

  • __cfduid

Decline all Services
Accept all Services